Stock PPCB PROPANC BIOPHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Propanc Biopharma, Inc.

Equities

PPCB

US74346N6022

Market Closed - OTC Markets
Other stock markets
 03:33:15 2024-07-12 pm EDT 		5-day change 1st Jan Change
0.00075 USD -10.71% Intraday chart for Propanc Biopharma, Inc. -20.00% -93.33%
Jun. 25 Propanc Biopharma, Inc. Receives Certificate of Grant for "Proenzymes Composition" Patent from Japanese Patent Office CI
Jun. 20 Propanc Biopharma, Inc. announced that it has received $0.03375 million in funding CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Propanc Biopharma Receives Certificate of Grant for Proenzymes Composition Patent from Japanese Patent Office
AQ
Propanc Biopharma, Inc. Receives Certificate of Grant for "Proenzymes Composition" Patent from Japanese Patent Office
CI
Propanc Biopharma, Inc. announced that it has received $0.03375 million in funding
CI
Propanc Biopharma, Inc. announced that it has received $0.041 million in funding from 1800 Diagonal Lending, LLC
CI
Propanc Biopharma, Inc. Enters into and Closed a Loan Agreement with an Investor
CI
Propanc Biopharma, Inc. announced that it has received $0.041 million in funding from 1800 Diagonal Lending, LLC
CI
Propanc Biopharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024
CI
Propanc Biopharma : Material Agreement - Form 8-K
PU
Propanc Biopharma Receives Certificate of Grant for Composition of Proenzymes for Cancer Treatment Patent from European Patent Office
AQ
Propanc Biopharma, Inc. Receives Certificate of Grant for ?Composition of Proenzymes for Cancer Treatment? Patent from European Patent Office
CI
Propanc Biopharma, Inc. announced that it has received $0.025 million in funding from GS Capital Partners LLC
CI
Propanc Biopharma's CEO Shares Views on Revolutionizing Cancer Treatment, an inside Look at Drug Development and Strategic Financing
AQ
Propanc Biopharma : Material Agreement - Form 8-K
PU
Propanc Biopharma, Inc. announced that it has received $0.046875 million in funding
CI
Propanc Biopharma to Host Corporate Update Call Highlighting Recent Progress and Positive Results from Compassionate Use Study
AQ
Propanc Biopharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023
CI
Propanc Biopharma Receives Certificate of Grant for PRP Foundation Patent from Canadian Intellectual Property Office
CI
Propanc Biopharma's Joint Research Partner Pushing Boundaries to Circumvent Chemotherapy Resistance Using PRP
AQ
Propanc Biopharma, Inc. announced that it has received $0.135 million in funding
CI
Propanc Biopharma, Inc. announced that it has received $0.045 million in funding
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PPCB Stock
  4. News Propanc Biopharma, Inc.